QUEGEN BIOTECH CO LTD has a total of 12 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2010. It filed its patents most often in WIPO (World Intellectual Property Organization), Republic of Korea and China. Its main competitors in its focus markets pharmaceuticals, foods and drinks and medical technology are SUZHOU ZHIHE STRUCTURAL PHARMACEUTICAL TECH CO LTD, MOMOYA KK and GYEONGBUK INST FOR BIO INDUSTRY.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Republic of Korea | 3 | |
#3 | China | 2 | |
#4 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Medical technology | |
#4 | Biotechnology | |
#5 | Organic fine chemistry | |
#6 | Environmental technology | |
#7 | Machines |
# | Technology | |
---|---|---|
#1 | Foods | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Special foods | |
#5 | Object sterilising | |
#6 | Climate change adaptation technologies | |
#7 | Microorganisms | |
#8 | Specific use of cosmetics | |
#9 | Fermentation | |
#10 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Jang Yong Man | 11 |
#2 | Lee Jong Dae | 9 |
#3 | Kim Je Kyoung | 9 |
#4 | Kim Min Ji | 8 |
#5 | Park Eun Ji | 7 |
#6 | Cho Moon Jae | 4 |
#7 | Kim Sung Hong | 4 |
#8 | Yang Chul Su | 4 |
#9 | Kim Young Mee | 4 |
#10 | Lim Youn Mook | 2 |
Publication | Filing date | Title |
---|---|---|
KR20200140755A | Composition comprising betaglucan for improving intestinal microflora and use thereof | |
KR20200140756A | Composition comprising betaglucan for improving intestinal microflora and use thereof | |
KR102161552B1 | Composition comprising betaglucan for improving intestinal microflora and use thereof | |
WO2018124386A1 | Pharmaceutical composition for preventing and treating tuberculosis, containing β-glucan and antituberculous drug as active ingredients | |
WO2010085119A2 | Beta-glucan-based scaffold for biological tissue engineering using radiation fusion technology, and production method therefor | |
CN102292113B | Beta-glucan-based scaffold for biological tissue engineering using radiation fusion technology, and production method therefor |